Prelude Capital Management’s Alto Neuroscience ANRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$25.1K	Sell	11,401 -2,244	-16%	-$4.94K	﹤0.01%	965
2025 Q1	$29.5K	Buy	13,645 +1,400	+11%	+$3.02K	﹤0.01%	1029
2024 Q4	$51.8K	Buy	+12,245	New	+$51.8K	﹤0.01%	1015